You are here : Home > Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor

Publications CNRGH

Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor

Published on 2 October 2023
Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor
Description
 
Date de publication02/08/2017
Auteurs
Louveau B, Tost J, Mauger F, Sadoux A, Podgorniak MP, How-Kit A, Pages C, Roux J, Da Meda L, Lebbe C and Mourah S
Revue
Année2,017
Département / Service
JACOB/CNRGH
Laboratoire
LEE
Impact Factor 
InstitutJACOB
url DOI10.1136/esmoopen-2017-000173

Retour à la liste